Company Description

BioCytics is a privately held health technology company that is using Autologous Adaptive Immune Cell Therapy (AAICT) to develop an immuno-oncology platform for treating solid tumors with the patient's own immune cells. AAICT is a revolutionary point-of-care cell manufacturing process designed to generate nongenetically modified effector cell fractions for all stages of all solid tumors.